rolipram has been researched along with Cirrhoses, Experimental Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gobejishvili, L | 1 |
| Barve, S | 1 |
| Breitkopf-Heinlein, K | 1 |
| Li, Y | 1 |
| Zhang, J | 1 |
| Avila, DV | 1 |
| Dooley, S | 1 |
| McClain, CJ | 1 |
| Ahloulay, M | 1 |
| Bankir, L | 1 |
| Lugnier, C | 1 |
| Le Bec, A | 1 |
| Poirel, O | 1 |
| Moreau, R | 1 |
| Lebrec, D | 1 |
2 other studies available for rolipram and Cirrhoses, Experimental Liver
| Article | Year |
|---|---|
Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bile Duct Diseases; Bile Ducts; Cyclic Nucleotide Phos | 2013 |
Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites.
Topics: Analysis of Variance; Animals; Ascites; Cyclic AMP; Disease Models, Animal; Glomerular Filtration Ra | 2005 |